{"cluster": 63, "subcluster": 1, "abstract_summ": "With no vaccines or drugs approved for prevention and treatment until now, all efforts at drug design and/or clinical trials of already approved drugs are worthy and creditable.Recently, the Dutch National Institute for Public Health and the Environment published treatment options for antiviral treatment for COVID-19 where chloroquine was suggested as first choice for off-label treatment, beside remdesivir en lopinavir/ritonavir.More randomized control clinical studies are warranted to determine the feasibility of these two drugs in treating COVID-19.Since the outbreak of COVID-19, chloroquine has been mentioned as a possible treatment.As antibody-based approaches are identified and advanced, promising small-molecule antivirals currently in clinical stage development should continue to be evaluated for filovirus diseases, with consideration of their added value in combination approaches with bundled supportive care, their penetration in tissues of interest, the absence of interaction with glycoprotein-based vaccines, and filoviral breadth.\u2022 Due to its mechanism of action and various anti-inflammatory effects, azithromycin is a promising medicine for the treatment of the coronavirus COVID-19.Chloroquine has been recommended by some authors to be used for the treatment of patients infected with this virus however chloroquine may have side effects and drug resistance problems.", "title_summ": "Macrolide treatment for COVID-19: Will this be the way forward?Update on use of chloroquine/hydroxychloroquine to treat coronavirus disease 2019 (COVID-19).[Chloroquine as a possible treatment for COVID-19].Recent successes in therapeutics for Ebola virus disease: no time for complacencyAzithromycin and SARS-CoV-2 infection: where we are now and where we are goingNovel therapeutic approaches for treatment of COVID-19A systematic review on use of aminoquinolines for the therapeutic management of COVID-19: Efficacy, safety and clinical trialsArtesunate: could be an alternative drug to chloroquine in COVID-19 treatment?", "title_abstract_phrases": "With no vaccines or drugs approved for prevention and treatment until now, all efforts at drug design and/or clinical trials of already approved drugs are worthy and creditable.Recently, the Dutch National Institute for Public Health and the Environment published treatment options for antiviral treatment for COVID-19 where chloroquine was suggested as first choice for off-label treatment, beside remdesivir en lopinavir/ritonavir.More randomized control clinical studies are warranted to determine the feasibility of these two drugs in treating COVID-19.[Chloroquine as a possible treatment for COVID-19].Since the outbreak of COVID-19, chloroquine has been mentioned as a possible treatment.In this commentary, we provide a background and history of chloroquine, the evidence for antiviral efficacy of chloroquine and the arguments for off-label use of chloroquine in COVID-19.Recent successes in therapeutics for Ebola virus disease: no time for complacencyThe PALM trial in the Democratic Republic of the Congo identified a statistically significant survival benefit for two monoclonal antibody-based therapeutics in the treatment of acute Ebola virus disease; however, substantial gaps remain in improving the outcomes of acute Ebola virus disease and for the survivors.\u2022 At the moment 21 clinical trials are being carried out on the use of azithromycin in COVID-19.Novel therapeutic approaches for treatment of COVID-19To date, there is no licensed treatment or approved vaccine to combat the coronavirus disease of 2019 (COVID-19), and the number of new cases and mortality multiplies every day."}